Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2 Pt 1
|
pubmed:dateCreated |
1988-4-11
|
pubmed:abstractText |
We have recently shown that substitution of Li+ for perfusate Na+ eliminates the HCO3(-)-rich choleresis produced by ursodeoxycholic acid (UDCA) in isolated perfused rat liver and that the increase in bile flow produced by both UDCA and taurocholic acid is partially inhibited by 1 mM amiloride. Although these findings are consistent with a role for Na+-H+ exchange in the choleresis produced by these bile acids, both Li+ substitution and amiloride affect other cellular processes, including Na+-K+-ATPase activity. We have now further explored both the relationship between UDCA-stimulated bile flow and biliary HCO3- secretion and the possible role of Na+-H+ exchange in this process by comparing the effects of amiloride with two of its more potent and presumably more specific analogues, 5-(N,N-dimethyl)amiloride hydrochloride (DMA) and 5-(N-ethyl-N-isopropyl)amiloride (EIA). In the absence of inhibitor, UDCA increased biliary HCO3- concentration ([HCO3-]) up to an apparent maximum of 60-70 mM, and bile flow and biliary HCO3- output appeared to be linearly related over a sixfold range of bile flow rates. Amiloride, DMA, and EIA each produced a concentration-dependent inhibition of UDCA-stimulated bile flow and biliary HCO3- output with an apparent rank order potency (EIA greater than DMA greater than amiloride) similar to that reported for inhibition of Na+-H+ exchange in other systems. None of the inhibitors significantly altered biliary UDCA output or the relationship between UDCA-induced bile flow and either biliary [HCO3-] or biliary HCO3- output. Effects of these inhibitors did not appear attributable either to nonspecific toxicity, as reflected by hepatic release of lactate dehydrogenase or K+, or to inhibition of hepatic Na+-K+-ATPase, measured as Na+-dependent uptake of 86Rb. In contrast to their effects on UDCA choleresis, these inhibitors had little or no effect on basal bile flow, biliary [HCO3-], and biliary HCO3- output. These findings indicate that UDCA-induced but not basal bile formation is closely coupled to biliary HCO3- concentration and output, and they provide additional evidence that UDCA choleresis requires an intact Na+-H+ exchange mechanism.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amiloride,
http://linkedlifedata.com/resource/pubmed/chemical/Bicarbonates,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cholagogues and Choleretics,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycholic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Rubidium,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Hydrogen Antiporter,
http://linkedlifedata.com/resource/pubmed/chemical/Ursodeoxycholic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
254
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
G232-41
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2831731-Amiloride,
pubmed-meshheading:2831731-Animals,
pubmed-meshheading:2831731-Bicarbonates,
pubmed-meshheading:2831731-Bile,
pubmed-meshheading:2831731-Carrier Proteins,
pubmed-meshheading:2831731-Cholagogues and Choleretics,
pubmed-meshheading:2831731-Deoxycholic Acid,
pubmed-meshheading:2831731-Dose-Response Relationship, Drug,
pubmed-meshheading:2831731-L-Lactate Dehydrogenase,
pubmed-meshheading:2831731-Male,
pubmed-meshheading:2831731-Potassium,
pubmed-meshheading:2831731-Rats,
pubmed-meshheading:2831731-Rats, Inbred Strains,
pubmed-meshheading:2831731-Rubidium,
pubmed-meshheading:2831731-Sodium,
pubmed-meshheading:2831731-Sodium-Hydrogen Antiporter,
pubmed-meshheading:2831731-Ursodeoxycholic Acid
|
pubmed:year |
1988
|
pubmed:articleTitle |
Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
|
pubmed:affiliation |
Department of Medicine, University of California School of Medicine, San Francisco 94143.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|